A Randomized Double Blinded and Placebo-Controlled Trial to Assess the Impact of Biophoton Therapy on Self-Grown Stem Cells

Study Enrollment Each potentially qualified volunteer will review the Informed Consent Form online (e-ICF) and Enrollment Criteria online (e-Criteria) first, then discuss the e-ICF and e-Criteria with the study team medical professional via telephone during the scheduled time. Each qualified volunteer will sign the e-ICF and send it to the Medical Office Coordinator. The Coordinator will assign the qualified volunteer a randomized subject number, then the volunteer will become a study participant.

Study Procedure We expect that the participant will stay in this clinical treatment for 2 weeks, or 4 weeks if the participants are randomly placed in a placebo group. The first 2 weeks of participation are double blinded to record the placebo effects, as each set of the study device is labelled with a unique code for use by only one participant. The change of the placebo device to the treatment device will be performed by the study device management team staff who will not inform the study participant nor study research staff who involve study data collection. Each participant assigned to the Control Group will be treated with the 4 placebo devices and placed on the 4 corners of the bed. Each participant assigned to the Treatment Group will receive 4 Biophoton generator devices and placed on the 4 corners of the bed. Each participant will use the Treatment or Control device for at least 8 hours every night for the 2 weeks during sleep. During the day, participants are welcome to bring the study devices and place them near the body during the daytime. At the end of the initial 2 weeks, study participants randomized to the Placebo group will be advised whether they will use the Open-Labeled product to treat them for 2 weeks. Each participant will be guided by study team staff to perform the following tests on their assigned testing days: a visual analog scale of pain, the standard SF-36 questionnaires (SF-36) for measuring life quality, and stem cell examination respectively at the Baseline, one and two weeks after using the study devices.

Study Supply All study devices (Placebo or Treatment) will be packed for easy use. Each participant will use the assigned devices during the 2-week study period (Treatment Group), or for 2+2 weeks (Placebo Group) after being switched to the Treatment group after the first two weeks of the placebo period.

Study Patient Population The adult who wants to increase stem cells without major health issues.

Investigational Product and Mode of Administration Tesla BioHealing Biophotonizer-A is an over-the-counter (OTC) medical device and it can be used by anyone who wants to increase blood circulation and reduce bodily pains. For this study, the active or inactive Biophotonizer-A will be labeled with a code. The participant and/or caregiver cannot know if the devices are active or inactive. When the participant places the devices close to the body, she/he may or may not receive life force energy. The participant will record changes in pain, quality of life at baseline and at the end of each week.